Does RASBURICASE Cause Product prescribing issue? 5 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 5 reports of Product prescribing issue have been filed in association with RASBURICASE (Elitek). This represents 0.6% of all adverse event reports for RASBURICASE.
5
Reports of Product prescribing issue with RASBURICASE
0.6%
of all RASBURICASE reports
1
Deaths
0
Hospitalizations
How Dangerous Is Product prescribing issue From RASBURICASE?
Of the 5 reports, 1 (20.0%) resulted in death.
Is Product prescribing issue Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for RASBURICASE. However, 5 reports have been filed with the FAERS database.
What Other Side Effects Does RASBURICASE Cause?
Tumour lysis syndrome (116)
Methaemoglobinaemia (92)
Off label use (90)
Product use in unapproved indication (76)
Bacterial infection (75)
Fungal infection (73)
Cellulitis (72)
Clostridium difficile colitis (72)
Lymphoid tissue hypoplasia (72)
Lymphopenia (72)
What Other Drugs Cause Product prescribing issue?
DUPILUMAB (1,715)
POLYETHYLENE GLYCOL 3350 (1,439)
LENALIDOMIDE (948)
OXYCODONE (646)
RIVAROXABAN (359)
ACETAMINOPHEN\OXYCODONE (347)
ETONOGESTREL (311)
ACETAMINOPHEN\HYDROCODONE (298)
CERTOLIZUMAB PEGOL (297)
CABOZANTINIB S-MALATE (294)
Which RASBURICASE Alternatives Have Lower Product prescribing issue Risk?
RASBURICASE vs RAVULIZUMAB
RASBURICASE vs RAVULIZUMAB-CWVZ
RASBURICASE vs REBAMIPIDE
RASBURICASE vs REBETOL
RASBURICASE vs REBIF